Vetigenics Inc.
PrivateLast Round
Seed
Feb 3, 2025
Total Funding Raised
$6M
Company Overview
Vetigenics Inc. is a clinical-stage animal health biotechnology company that develops targeted antibody therapies for pets.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Vetigenics Inc. Comparables
Compare Vetigenics Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vetmab Biosciences | 85% | |
| MabGenesis株式会社 | 82% | |
| Jenga Biosciences | 74% |
Vetigenics Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Feb 3, 2025 | ||||
| Grant | Nov 2, 2023 | ||||
| Grant | Nov 2, 2023 |
Vetigenics Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| National Cancer Institute | Grant |
| American Kennel Club Canine Health Foundation | Grant |
| V Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 3, 2025
$6M raised in Seed round.
Vetigenics Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access